跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Bdocin 150
Approved
STANDARD
Bdocin 150
BDR Pharmaceuticals International Pvt. Ltd. (Oncology Unit)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d2368be62ed17f95
Company
BDR Pharmaceuticals International Pvt. Ltd. (Oncology Unit)
Type
Standard
Approval Details
Approval Id
d2368be62ed17f95
Drug Approval Philippines Name
Bdocin 150
Product Name
Bdocin 150
Registration Number
DRP-8920
Brand Name
Bdocin 150
Generic Name
Capecitabine
Dosage Form
Film-Coated Tablet
Dosage Strength
150 mg
Manufacturer
BDR Pharmaceuticals International Pvt. Ltd. (Oncology Unit)
Importer
Ambica International Trading Corp.
Distributor
Ambica International Trading Corp.
Issuance Date
29 November 2024
Expiry Date
24 June 2030
Pharmacologic Category
Antineoplastic (Pyrimidine Analogue)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d2368be62ed17f95
Type
Standard
Back to Philippines FDA Approvals
Bdocin 150 - Philippines FDA Drug Approval Details